Legal / IP

AstraZenecaBoehringer Ingelheim

Merck Loses Third Circuit Appeal as Court Upholds Medicare Drug Price Negotiations Under IRA

The U.S. Court of Appeals for the Third Circuit ruled against Merck & Co., Inc. (MSD; NYSE: MRK), rejecting the drugmaker's claim that Medicare drug price negotiations violate the First…

WuXi AppTec Wins Preliminary Injunction Against DoD 1260H Designation

WuXi AppTec Wins Preliminary Injunction Against DoD 1260H Designation

Novo Nordisk Sues Eli Lilly Over Alleged False Advertising of Zepbound and Mounjaro in GLP-1 Market

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
Hainan Poly Pharm Faces Delisting After CSRC Imposes Strict Penalties for Financial Misconduct
Poly PharmSHE: 300630

Hainan Poly Pharm Faces Delisting After CSRC Imposes Strict Penalties for Financial Misconduct

SMPA Suspends Indobufen Procurement After Patent Infringement Verdict
Huadong MedicinePatents

SMPA Suspends Indobufen Procurement After Patent Infringement Verdict

AstraZeneca Faces Class Action Lawsuits Over China Legal Issues
AstraZenecaAZ

AstraZeneca Faces Class Action Lawsuits Over China Legal Issues

Chipscreen's Epidaza Patent Faces Invalidation Request Review
CancerChia Tai Tianqing Pharmaceutical

Chipscreen’s Epidaza Patent Faces Invalidation Request Review

Show More